|
KIAA0317 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.27190000004585E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.82569999999505E-05 |
| Normal-vs-Stage2 |
7.524100E-02 |
| Normal-vs-Stage3 |
2.72599999995293E-06 |
| Normal-vs-Stage4 |
6.81399999757915E-08 |
| Stage1-vs-Stage2 |
9.551600E-02 |
| Stage1-vs-Stage3 |
1.921400E-01 |
| Stage1-vs-Stage4 |
1.543680E-02 |
| Stage2-vs-Stage3 |
1.831950E-02 |
| Stage2-vs-Stage4 |
2.322200E-03 |
| Stage3-vs-Stage4 |
2.916200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.25189999994535E-06 |
| Normal-vs-AfricanAmerican |
1.122990E-03 |
| Normal-vs-Asian |
2.779100E-03 |
| Caucasian-vs-AfricanAmerican |
7.519800E-01 |
| Caucasian-vs-Asian |
5.965000E-01 |
| AfricanAmerican-vs-Asian |
5.457200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.32939999972915E-07 |
| Normal-vs-Female |
3.93600000000438E-05 |
| Male-vs-Female |
1.252780E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.176300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.77369999998511E-06 |
| Normal-vs-Age(61-80Yrs) |
1.801330E-04 |
| Normal-vs-Age(81-100Yrs) |
1.418070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.711600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.648800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.208200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.309400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.786000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.487800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.238600E-01 |
| Classical-VS-Follicular |
9.487400E-01 |
| Classical-VS-Other |
1.025220E-01 |
| Classical-VS-Normal |
4.09319999999935E-05 |
| Tall-VS-Follicular |
8.832400E-01 |
| Tall-VS-Other |
1.336180E-01 |
| Tall-VS-Normal |
2.883500E-03 |
| Follicular-VS-Other |
1.665840E-01 |
| Follicular-VS-Normal |
1.157710E-03 |
| Other-VS-Normal |
1.255770E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.64220000000004E-05 |
| Normal-vs-N1 |
1.14579999999087E-06 |
| N0-vs-N1 |
7.974200E-02 |
|
|
